Global Rare Hemophilia Factors (I, II, VII) Market Research Report 2023-2030 Featuring Major Innovators - Novo Nordisk, Biogen, Bayer, Pfizer, Shire Baxalta, CSL Behring, & Bio Products Laboratory
October 03, 2023 10:03 ET
|
Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Rare Hemophilia Factors Market Size, Share & Trends Analysis Report By Type (Factor I, Factor II, Factor VII), By Treatment (Factor Concentrates,...